Published in Virology on June 01, 1994
Complete sequence and genomic analysis of murine gammaherpesvirus 68. J Virol (1997) 7.71
Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation. J Exp Med (1998) 4.51
Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J Virol (1995) 4.22
Regulation of apoptosis by viral gene products. J Virol (1997) 3.67
A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc Natl Acad Sci U S A (1997) 2.63
Three distinct regions of the murine gammaherpesvirus 68 genome are transcriptionally active in latently infected mice. J Virol (1999) 2.56
Viral control of mitochondrial apoptosis. PLoS Pathog (2008) 2.21
Apoptosis-inducing and apoptosis-preventing functions of poliovirus. J Virol (1995) 1.88
Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells. J Virol (1997) 1.78
Induction of apoptosis by La Crosse virus infection and role of neuronal differentiation and human bcl-2 expression in its prevention. J Virol (1996) 1.50
The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor. J Virol (1998) 1.46
Caspase activation and specific cleavage of substrates after coxsackievirus B3-induced cytopathic effect in HeLa cells. J Virol (1998) 1.41
Activators of the Epstein-Barr virus lytic program concomitantly induce apoptosis, but lytic gene expression protects from cell death. J Virol (2001) 1.34
Targeting the Bcl-2 family for cancer therapy. Expert Opin Ther Targets (2012) 1.33
Herpesvirus saimiri encodes a functional homolog of the human bcl-2 oncogene. J Virol (1997) 1.30
The ability of BHRF1 to inhibit apoptosis is dependent on stimulus and cell type. J Virol (1997) 1.19
The Epstein-Barr virus Bcl-2 homolog, BHRF1, blocks apoptosis by binding to a limited amount of Bim. Proc Natl Acad Sci U S A (2009) 1.08
BH3 domains define selective inhibitory interactions with BHRF-1 and KSHV BCL-2. Cell Death Differ (2007) 1.07
Role of the Crosstalk between Autophagy and Apoptosis in Cancer. J Oncol (2013) 1.07
Epstein-Barr virus BALF1 is a BCL-2-like antagonist of the herpesvirus antiapoptotic BCL-2 proteins. J Virol (2002) 1.05
The essential role of evasion from cell death in cancer. Adv Cancer Res (2011) 1.05
Viruses and apoptosis. Int J Exp Pathol (2001) 1.03
Induction of caspase activation and cleavage of the viral nucleocapsid protein in different cell types during Crimean-Congo hemorrhagic fever virus infection. J Biol Chem (2010) 1.02
Identification of a novel antiapoptotic protein, GAM-1, encoded by the CELO adenovirus. J Virol (1997) 0.96
Functional differences between BHRF1, the Epstein-Barr virus-encoded Bcl-2 homologue, and Bcl-2 in human epithelial cells. J Virol (1998) 0.94
Epstein-Barr virus BHRF1 protein protects intestine 407 epithelial cells from apoptosis induced by tumor necrosis factor alpha and anti-Fas antibody. J Virol (1997) 0.94
Temporal changes in chromatin, intracellular calcium, and poly(ADP-ribose) polymerase during Sindbis virus-induced apoptosis of neuroblastoma cells. J Virol (1996) 0.91
Negative autoregulation of Epstein-Barr virus (EBV) replicative gene expression by EBV SM protein. J Virol (2009) 0.86
The Non-structural Protein of Crimean-Congo Hemorrhagic Fever Virus Disrupts the Mitochondrial Membrane Potential and Induces Apoptosis. J Biol Chem (2015) 0.81
Interplay between PKCδ and Sp1 on histone deacetylase inhibitor-mediated Epstein-Barr virus reactivation. J Virol (2010) 0.80
Complications of gamma knife surgery for Parkinson disease. Arch Neurol (2001) 3.97
Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell (1994) 3.86
A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. EMBO J (1995) 3.70
Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation. Proc Natl Acad Sci U S A (1995) 3.28
Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene (1995) 2.89
Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis. Nucleic Acids Res (1989) 2.72
Physical mapping of a large-plaque mutation of adenovirus type 2. J Virol (1979) 2.50
Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein. Proc Natl Acad Sci U S A (1991) 2.17
BH3-only proteins in apoptosis and beyond: an overview. Oncogene (2008) 2.13
Identification of a cellular protein that specifically interacts with the essential cysteine region of the HIV-1 Tat transactivator. Virology (1996) 2.12
Interaction between a cellular protein that binds to the C-terminal region of adenovirus E1A (CtBP) and a novel cellular protein is disrupted by E1A through a conserved PLDLS motif. J Biol Chem (1998) 2.06
Adenovirus 2 Ip+ locus codes for a 19 kd tumor antigen that plays an essential role in cell transformation. Cell (1983) 2.01
Adenovirus E1B-19K/BCL-2 interacting protein BNIP3 contains a BH3 domain and a mitochondrial targeting sequence. J Biol Chem (1998) 1.81
Distinct cis-acting regions in U3 regulate trans-activation of the human spumaretrovirus long terminal repeat by the viral bel1 gene product. Nucleic Acids Res (1991) 1.63
Binding of CtIP to the BRCT repeats of BRCA1 involved in the transcription regulation of p21 is disrupted upon DNA damage. J Biol Chem (1999) 1.57
Role of the PLDLS-binding cleft region of CtBP1 in recruitment of core and auxiliary components of the corepressor complex. Mol Cell Biol (2007) 1.49
Mutants in a conserved region near the carboxy-terminus of HIV-1 Rev identify functionally important residues and exhibit a dominant negative phenotype. Virology (1990) 1.48
19-kDa tumor antigen coded by early region E1b of adenovirus 2 is required for efficient synthesis and for protection of viral DNA. J Biol Chem (1984) 1.47
A unique pattern of integrated viral genes in hamster cells transformed by highly oncogenic human adenovirus 12. Cell (1976) 1.45
An N-terminal region of adenovirus E1a essential for cell transformation and induction of an epithelial cell growth factor. Oncogene (1988) 1.41
Enhanced infectivity of adenovirus type 2 DNA and a DNA-protein complex. J Virol (1978) 1.40
Enhanced ras oncogene mediated cell transformation and tumorigenesis by adenovirus 2 mutants lacking the C-terminal region of E1a protein. Oncogene (1989) 1.40
Nicotinamide adenine dinucleotide stimulates oligomerization, interaction with adenovirus E1A and an intrinsic dehydrogenase activity of CtBP. FEBS Lett (2003) 1.38
Comparison of MPTP-induced changes in spontaneous neuronal discharge in the internal pallidal segment and in the substantia nigra pars reticulata in primates. Exp Brain Res (1999) 1.35
The CtBP binding domain in the adenovirus E1A protein controls CR1-dependent transactivation. Nucleic Acids Res (1996) 1.33
Adenovirus transforming 19-kD T antigen has an enhancer-dependent trans-activation function and relieves enhancer repression mediated by viral and cellular genes. Genes Dev (1987) 1.30
Evidence that a second tumor antigen coded by adenovirus early gene region E1a is required for efficient cell transformation. Proc Natl Acad Sci U S A (1985) 1.27
Synergistic activation of the human immunodeficiency virus type 1 promoter by the viral Tat protein and cellular transcription factor Sp1. J Virol (1992) 1.25
Relationship between the transforming and transcriptional regulatory functions of adenovirus 2 E1a oncogene. Virology (1987) 1.24
Heterologous basic domain substitutions in the HIV-1 Tat protein reveal an arginine-rich motif required for transactivation. EMBO J (1991) 1.24
Functional dissection of the human spumaretrovirus transactivator identifies distinct classes of dominant-negative mutants. J Virol (1993) 1.24
p53-independent apoptotic and necrotic cell deaths induced by adenovirus infection: suppression by E1B 19K and Bcl-2 proteins. Cell Growth Differ (1995) 1.23
BH3-only protein BIK induces caspase-independent cell death with autophagic features in Bcl-2 null cells. Oncogene (2007) 1.22
Pre-early polypeptides of bacteriophages T5 and BF23. J Virol (1977) 1.21
Functional dissection of Bfl-1, a Bcl-2 homolog: anti-apoptosis, oncogene-cooperation and cell proliferation activities. Oncogene (1998) 1.17
Acetylation by p300 regulates nuclear localization and function of the transcriptional corepressor CtBP2. J Biol Chem (2005) 1.17
Structural determinants present in the C-terminal binding protein binding site of adenovirus early region 1A proteins. J Biol Chem (1998) 1.17
Association of class I histone deacetylases with transcriptional corepressor CtBP. FEBS Lett (2003) 1.16
Critical requirement of BAX for manifestation of apoptosis induced by multiple stimuli in human epithelial cancer cells. Cancer Res (2002) 1.16
Functional substitution of the basic domain of the HIV-1 trans-activator, Tat, with the basic domain of the functionally heterologous Rev. Virology (1990) 1.15
Comparison of antibody-dependent cellular cytotoxicity and complement-dependent antibody lysis of herpes simplex virus-infected cells as methods of detecting antiviral antibodies in human sera. J Clin Microbiol (1977) 1.15
Genetic identification of adenovirus type 5 genes that influence viral spread. J Virol (2006) 1.14
Functional domains of the HIV-1 rev gene required for trans-regulation and subcellular localization. Virology (1990) 1.13
Modulation of mitochondrial Ca(2+) homeostasis by Bcl-2. J Biol Chem (1999) 1.12
bfl-1, a bcl-2 homologue, suppresses p53-induced apoptosis and exhibits potent cooperative transforming activity. Cancer Res (1996) 1.11
mRNA from the transforming segment of the adenovirus 2 genome in productively infected and transformed cells. J Virol (1976) 1.11
Unmasking of a proliferation-restraining activity of the anti-apoptosis protein EBV BHRF1. Oncogene (1996) 1.10
BNIP3alpha: a human homolog of mitochondrial proapoptotic protein BNIP3. Cancer Res (1999) 1.09
Phosphorylation of the pro-apoptotic protein BIK: mapping of phosphorylation sites and effect on apoptosis. J Biol Chem (2000) 1.08
Requirement of a phage-induced 5'-exonuclease for the expression of late genes of bacteriophage T5. Proc Natl Acad Sci U S A (1973) 1.08
Proteasomes modulate balance among proapoptotic and antiapoptotic Bcl-2 family members and compromise functioning of the electron transport chain in leukemic cells. J Immunol (2001) 1.03
The pro-apoptotic protein, Bik, exhibits potent antitumor activity that is dependent on its BH3 domain. Mol Cancer Ther (2001) 1.01
Adenovirus cyt+ locus, which controls cell transformation and tumorigenicity, is an allele of lp+ locus, which codes for a 19-kilodalton tumor antigen. J Virol (1984) 1.01
Colorimetric determination of patulin produced by Penicillium patulum. J Assoc Off Anal Chem (1982) 1.00
Deletion of a nonconserved region of Bcl-2 confers a novel gain of function: suppression of apoptosis with concomitant cell proliferation. Cancer Res (1996) 0.99
Stereotaxic intrastriatal implantation of human retinal pigment epithelial (hRPE) cells attached to gelatin microcarriers: a potential new cell therapy for Parkinson's disease. J Neural Transm Suppl (2003) 0.98
Dual role of gene D5 in the development of bacteriophage T5. Nature (1974) 0.98
Activation of the adenovirus 2 protein IX promoter by DNA replication in a transient expression assay. Nucleic Acids Res (1987) 0.97
Evaluation of a novel solubilized formulation of ibuprofen in the treatment of migraine headache: a randomized, double-blind, placebo-controlled, dose-ranging study. Cephalalgia (2000) 0.97
Adenovirus type 5 E1A and E6 proteins of low-risk cutaneous beta-human papillomaviruses suppress cell transformation through interaction with FOXK1/K2 transcription factors. J Virol (2010) 0.97
Functional dissection of the pro-apoptotic protein Bik. Heterodimerization with anti-apoptosis proteins is insufficient for induction of cell death. J Biol Chem (1997) 0.97
The carboxy-terminal transcription enhancement region of the human spumaretrovirus transactivator contains discrete determinants of the activator function. J Virol (1993) 0.97
Hinf family: a novel repeated DNA family of the human genome. Nature (1983) 0.96
Transforming genes among three different oncogenic subgroups of human adenoviruses have similar replicative functions. J Virol (1981) 0.95
Silencing of human immunodeficiency virus long terminal repeat expression by an adenovirus E1a mutant. Proc Natl Acad Sci U S A (1990) 0.95
Bak functionally complements for loss of Bax during p14ARF-induced mitochondrial apoptosis in human cancer cells. Oncogene (2006) 0.95
Regulation of apoptosis by a Caenorhabditis elegans BNIP3 homolog. Oncogene (1998) 0.94
Immortalization of rat embryo fibroblasts by an adenovirus 2 mutant expressing a single functional E1a protein. J Virol (1985) 0.94
Changes in C-terminal binding protein 2 (CtBP2) corepressor complex induced by E1A and modulation of E1A transcriptional activity by CtBP2. J Biol Chem (2006) 0.94
Regulation of expression of late genes of bacteriophage T5. J Virol (1974) 0.94
Structural analysis of the human pro-apoptotic gene Bik: chromosomal localization, genomic organization and localization of promoter sequences. Gene (2000) 0.93
Evidence for involvement of BH3-only proapoptotic members in adenovirus-induced apoptosis. J Virol (2007) 0.93
Functional substitution identifies a cell survival promoting domain common to adenovirus E1B 19 kDa and Bcl-2 proteins. Oncogene (1995) 0.92
Mutational analysis of the transforming and apoptosis suppression activities of the adenovirus E1B 175R protein. Gene (1993) 0.92
Functional comparison of the basic domains of the Tat proteins of human immunodeficiency virus types 1 and 2 in trans activation. J Virol (1992) 0.92
Anesthetic protocol: propofol use in Rhesus macaques (Macaca mulatta) during magnetic resonance imaging with stereotactic head frame application. Brain Res Brain Res Protoc (2001) 0.90
A potent cell death activity associated with transient high level expression of BCL-2. J Biol Chem (1998) 0.90
Selective induction of toxicity to human cells expressing human immunodeficiency virus type 1 Tat by a conditionally cytotoxic adenovirus vector. Proc Natl Acad Sci U S A (1990) 0.90